Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by EquityInveston May 15, 2018 10:55pm
81 Views
Post# 28036715

RE:RE:Question: ACB & CRON

RE:RE:Question: ACB & CRONThank an you MA, I agree with you that all will run except ACB.  I do own a bunch of APH and yes, I'm up on those already and wondering when to sell.  Might be oversold now?

I was just thinking of Cronos to replace my ACB as they are comparable in sp.  Will look at THCX as an alternative.  Thank you again.


MartialArts wrote:
EI, all these names will run except ACB which will be seeing selling pressure not only from ACB holders connecting the dots but also from LEAF holders selling on the market to get cash versus gettting the now famous "ACB monopoly money" that loses value with dillution.

CRON has zero KG supply deal with provinces so far.  They also have very weak production with only 47K KG in 2018 and 68K KG in 2019. What CRON has is Nasdaq access to US investors but WEED is getting that with a NYSE CGC ticker listing.

CRON's financials aren't very good with one of the lower 2019 EBITDA of just $47. The only one works is THCX with $32.

Have you looked at APH again?  I'd be curious to know how you feel about it.  Post in public or private.  If there's any warts I'm missing, I'd rather know since I've very bullish on both APH and WEED.  CRON had its bump and WEED will suck US investor's attention since it dominates on production and is second to APH on the financials.


Bullboard Posts